Cotinine Screening Devices Market
Market Insights on Cotinine Screening Devices covering sales outlook, demand forecast & up-to-date key trends
Cotinine Screening Devices Market by Device Type, Sample & Region - Forecast 2022 - 2032
Global Cotinine Screening Devices Market Outlook (2022-2032)
[261 Pages Report] The global cotinine screening devices market recorded sales worth US$ 429.9 Million in the year 2021. The market is expected to expand at a cumulative CAGR of 4.7% and will grow 1.4X by the end of 2032, in which the sales are anticipated to be worth US$ 645 Million. This growth can be attributed to the following factors:
- Rising usages of cotinine screening devices in various workspaces
- The significance of cotinine screening tools as important risk indicators in life insurance tests
- Regional governments introducing smoking cessation initiatives
Data Points |
Market Insights |
Market Value 2022 |
U.S. $ 450.3 Mn |
Market Value 2029 |
U.S. $ 621.4 Mn |
CAGR 2022-2029 |
4.7% |
Share of top 5 countries |
71.9% |
Key Players |
The Key players of the Cotinine Screening Devices market are Abbott Laboratories, AlcoPro, Jant Pharmacal Corporation, Sinocare Inc., Mossman Associates, Nano-Ditech Corp, LifeSign LLC, ALFA Scientific, Ameritek USA., Hangzhou Clongene Biotech Co., and Germaine Laboratories, Inc. |
New Developments are enhancing Demand in the Global Market
High-performance Thin Layer Chromatography (HPTLC) has become a successful method for the creation and measurement of biomarkers. A significant development in the healthcare sector is the adoption of HPTLC as a reliable screening node for cotinine. The resurrected usage of HPTLC will open up new business prospects for manufacturers of cotinine screening equipment across the world.
The global market for cotinine screening devices is predicted to have greater competition over the coming ten years. The increased need for better methods of analyzing and diagnosing lung disorders has created new market possibilities for vendors. Another potential possibility for manufacturers is the use of cotinine in forensic testing and analysis.
Let us know your requirement to get
100% FREE customization
Smoking Cessation campaigns to boost the use of these devices
Campaigns aimed at quitting smoking encourage people to try quitting smoking several times. These initiatives also seek to raise awareness of the many methods of quitting. Through these efforts, the negative effects of continued smoking are also emphasized.
People now have more information regarding nicotine and tobacco's ingredients. To monitor their health, people willingly undergo cotinine testing. Therefore, it is anticipated that cotinine screening tools will become more common in the next few years. To combat the growing prevalence of smoking habits, the medical community has partnered with top pharmaceutical firms. Long-term smoking's impacts on human lungs have emerged as a major field of study in medicine.
Cotinine is becoming crucial for Medical Treatments:
The fact that the alkaloid is widely used to treat PTSD is important from the standpoint of the growing market. Additionally, employing cotinine to treat mental illnesses has grown to be a well-known practice in the healthcare sector.
Cotinine aids in the management and control of schizophrenia and other conditions of a similar kind. Therefore, it is reasonable to anticipate that the world market for cotinine screening equipment will follow an upward development trajectory.
The US to dominate the Global Cotinine Screening Devices Market during 2022-2032
According to the American Lung Association, smoking is the primary factor in 1 out of every 5 fatalities in the country. Serious health problems are being caused by the growing number of adults and kids who smoke. In America, about 14% of individuals have a smoking addiction. The American Lung Association, therefore, imposes a national cigarette tax as well as other tobacco product taxes to control the use of tobacco and nicotine content.
In 2020, the typical state cigarette tax was about US$ 1.82 per pack. Additionally, the American Lung Association developed health insurance plans, initiatives, and policies for smoke-free workplace regulations. These elements support the development of cotinine screening tools. Thus, in 2021, the United States had the greatest penetration rate for cotinine screening equipment.
In the year 2021, the cotinine screening devices market accounted for 8.1 percent of the global drug screening market, with sales of $ 5.3 billion. Increased use of cotinine screening devices in the workplace, the importance of drug-free recruiting, and the need for screening devices in insurance calculations are just a few of the important drivers driving this market's growth.
Cotinine is an alkaloid substance, formed in the human body after the consumption of nicotine. Cotinine is used for testing substance abuse in people because it stays in the human body for approximately 8 to 10 days. Cotinine is a biomarker indicating tobacco use.
Mandatory cotinine screening tests to hire employees is expected to rise the number of tests as well as products requirement in the market The sporting events have added nicotine to the list of drugs to be screened which is anticipated to propel the demand for cotinine screening devices around the world. Random checking of students at schools in North America as well as in East Asia also adds up to the growing demand for these devices. Moreover, compulsory screening of armed forces personnel before induction is another reason generating the demand for cotinine screening devices around the world over the forecast period.
The contract manufacturing of Cotinine screening devices in emerging countries is rising and favoring the revenue generation for the key players. Marketing rights of manufacturers are undertaken by marketing entities to increase the promotion of cotinine screening devices, along with the license of available products to distribute exclusively in the other markets. The direct presence through the deployment of the salesforce in remote and smaller markets is one of the actions taken by players to increase the demand for these devices. E-Commerce and online trading through portals accessing online payment also attributes to the rising adoption of these devices for the detection of substance abuse.
Cassettes held 62.9% market share, by the value of the overall cotinine screening devices market in the year 2021 and are expected to grow at a cumulative CAGR of 5.1% and will record sales worth U.S. $ 402.2 Mn by the end of 2029. The growing tobacco use amongst the younger generation is one of the key factors which is fueling the demand for cotinine screening devices market around the globe.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystHow The Market Progressed Till June 2022?
Particulars |
Details |
H1, 2021 |
4.69% |
H1, 2022 Projected |
4.71% |
H1, 2022 Outlook |
4.61% |
BPS Change - H1, 2022 (O) – H1, 2022 (P) |
(-) 10 ↓ |
BPS Change – H1, 2022 (O) – H1, 2021 |
(-) 9 ↓ |
FMI delivers a comparative study of the global cotinine screening devices market's growth rates and development prospects. As a result of the impact of macro and industrial variables, the market is influenced by an increase in patient base and product adoption rate.
Contract manufacturing of cotinine screening devices in emerging nations, and the introduction of e-commerce, and online trading with accessible online payment for such devices are all important trends in this market.
According to FMI, the market growth rate of cotinine screening devices is expected to decline by 09 Basis Point Share (BPS) in H1-2022 compared to H1-2021. Further comparison between the values for H1-2022 outlook and H1-2022 projected showed a dip of 10 BPS.
Due to the lack of evaluation of inexpensive single-line test strips for cotinine screening, key aspects associated in the lowering of BPS are attributed to the differential qualitative dichotomization of smokers and non-smokers.
The importance of cotinine screening devices as significant indications of risk in life insurance testing, as well as the introduction of smoking cessation programs by regional governments, are two positives for the sector.
2014-2021 Cotinine Screening Devices Demand Outlook Compared to 2022-2029 Forecast
According to Future Market Insights, the cotinine screening devices market expanded at a cumulative CAGR of 4.2% between 2014 and 2021. The market grew 1.3X during this period and is expected to follow a similar trend over the forecast period.
According to the Centre for Disease Control and Prevention, approximately 34.1 million people in the U.S. smoked cigarettes in the year 2019. Along with the use of regular cigarettes, the use of vaping or electronic cigarettes has been on the rise in the past few years as well. According to a survey conducted in the U.S., it was estimated that by the end of 2021, around 55 million people would be using e-cigarettes in the world.
As per CDC, around 33% of women smokers under Medicaid deny the use of tobacco during pregnancy. A recent study carried out indicated that a higher percentage of low-income pregnant women have a positive opinion about using urine cotinine tests to promote smoking cessation during pregnancy. The study also finds out that close to 90% of pregnant women favour nicotine testing during the pregnancy but also fear if cotinine tests positive.
Various functional attributes of these screening devices give them a competitive edge over the laboratory-based cotinine screening techniques, such as ease of use, convenience, and cost-effectiveness. These factors will help the cotinine screening devices to gain preference in the world. These screening devices are also preferred by insurance providers, the majority used in smoking cessation programs and rehabilitation centres.
The cotinine screening devices are portable, which reduces the cost of logistics such as sample handling, sample delivery to the laboratories, generation of reports, etc. These devices also reduce the time taken in screening as they give the results within a few minutes. These devices can be used anywhere according to the preference of the consumers, which also improve the adoption rate. All these factors are constantly propelling the demand of this market around the globe.
Manufacturers are concentrating their efforts on developing cotinine screening equipment that is simple to use and provide quick findings. Manufacturers are responding to the sensitivities around distinct end-use cases by producing devices with features that comply with appropriate regulatory standards. The major players in the cotinine screening devices market are competing to increase the production of cassettes and strips, as these are the two most 'in-demand' forms.
The key players of this industry are entering into strategic agreements and partnerships acquiring subsidiaries to enhance their market presence and expand into the diagnostic testing market around the world.
In May 2018, AlcoPro Inc., a drug and alcohol testing products company announced the acquisition of Kahntact USA to improve their market presence around the world.
In June 2019, PTS Diagnostics announced their co-branded agreement with eTrueNorth, which is an integrated pharmacy-based clinical services network to enhance their services and close the gaps in healthcare and wellness screenings.
In January 2020, Jant Pharmacal Corporation announced the procurement of a contract with Vizient Inc., for their entire line of rapid test kits.
The cotinine screening devices market is consolidated with players such as Abbott Laboratories, AlcoPro, Jant Pharmacal Corporation, Sinocare Inc., Mossman Associates, Nano-Ditech Corp, LifeSign LLC, ALFA Scientific, Ameritek USA., Hangzhou Clongene Biotech Co., and Germaine Laboratories, Inc.
Future Market Insights expects the global cotinine screening devices market to expand at a cumulative CAGR of 4.7% over the forecast period (2022-2029) owing to the efforts taken by the key players to expand in the global market.

A unified Market Research Subscription Platform, built for today's disparate research needs.
What are the opportunities for various manufacturers of the cotinine screening devices industry?
The growing number of smokers worldwide is expected to provide high growth opportunities for the test providers and cotinine screening device manufacturers. According to the National Institute of Drug Abuse, alcohol, tobacco and illicit drugs together create an economic burden of nearly US$ 700 billion in the U.S. through related costs, lost work productivity and healthcare, which represents the vast opportunity for the market growth.
Technological advances related to sample collection and efforts of the manufacturers to create easy to use disposable test kits are expected to create high demand for cotinine screening products. Manufacturers are focusing on using samples other than urine, such as saliva and hair samples, which is less embarrassing for individuals being tested.
What are the restraining factors for this market?
The decrease in the reimbursement rate for undergoing tobacco abuse testing may hamper the revenue growth of the stakeholders in the cotinine screening devices market. For instance in June 2015 Centers for Medicare and Medicaid Services reduced the reimbursement coverage to only two G codes for drug abuse testing, one for presumptive testing and one for definitive testing. The decrease in reimbursement may directly influence the number of drug abuse tests performed in the U.S., as low reimbursement would lead to out-of-pocket spending of the customers. Although the cost of cotinine screening devices is low as compared to the other drug abuse testing devices cotinine testing volume can also be affected adversely with an overall decrease in the drug abuse reimbursement as many cotinine screening tests are performed as part of drug abuse testing.
The adoption of cotinine testing is limited to the general population for the evaluation. Although various healthcare facilities carry out cotinine testing on regular basis for their employees many of them exclude current employees from it and carry out screening on new employees in the facility. Despite many employers across various countries are adopting cotinine screening, the pace at which the adoption is rising is much slower compared to other screening tests used for the drug abuse. Lack of immediate adverse effects makes cotinine testing’s importance go unnoticed by various employers. Low adoption of cotinine testing in rehabilitation centres as well is another reason, which may limit the growth of the market.
Country-wise Insights
Will the U.S. remain a key market for cotinine screening devices?
The American Lung Association has been playing a major role in the lives of the people helping them to quit smoking. Their program “Freedom From Smoking®” has helped people for 35 years and is ranked one of the best tobacco cessation programs in the world. Other programs such as Smokefree, Quit for Life also operate in the U.S. The more efforts taken by the government as well as non-profit organizations in the country to stop tobacco use attributes to the high share of the U.S. in the cotinine screening devices market in North America. The U.S. accounted for 97.0% of the market share, by the value of the total market in North America in the year 2021.
How does the cotinine screening devices market look in Germany?
Around 28% of the population, aged 15 and more in Germany smoked cigarettes regularly, in the year 2018. The government of Germany laid down some laws to curb smoking and protect the non-smoking people and the country such as “The protection of Young Persons Act” and “the Federal Non-smokers protection act”. These laws and other smoking cessation efforts which are taken by the government fuel the demand for cotinine screening devices in Germany. The sales of this market were recorded to be U.S. $ 40.0 Mn in the year 2021, and the market is expected to grow at a cumulative CAGR of 4.9% over the forecast period in Germany.
Why does India hold the highest market share in the South Asia cotinine screening devices market?
According to the WHO tobacco statistics of India, the economic burden attributed to tobacco use in India during the year 2018 accounted for U.S. $ 27. 5 Bn. Nearly 29% of India’s population regularly smoked cigarettes or some other form of tobacco in the same year, which made India the second-largest consumer of tobacco in the world. Thus, India attributed to the highest share of this market in South Asia, which was 29.5% in the year 2021.
Category-wise Insights
What is the global cotinine screening market value?
The global cotinine screening devices market was valued at U.S. $ 429.9 Mn in the year 2021 and is expected to expand at a CAGR of 4.7% over the forecast period (2022-2029)
Which device holds the highest market share in the global cotinine screening devices market?
Cassettes held 62.9% market share, by the value of the overall cotinine screening devices market in the year 2021 and are expected to grow at a cumulative CAGR of 5.1% and will record sales worth U.S. $ 402.2 Mn by the end of 2029. Since cassettes are the easiest device to test the presence of cotinine in the human body, they are the most preferred device in the industry. Various rapid testing kits used by workplace screening centres use cassettes as their diagnostic tools.
Which sample type recorded maximum sales of the global cotinine screening devices market?
Saliva samples attributed 61.0% market share, by the value of the total market in the year 2021 and this segment is expected to expand at a CAGR of 4.8% over the forecast period with the anticipated sales worth U.S. $ 382.8 Mn by the end of 2029. The consumers prefer this type of sample for testing, which explains the high market share.
Which end-user held the highest market share of the global cotinine screening devices market?
Laboratories held 38.5% market share, by the value of the global market in the year 2021 with the sales recorded worth U.S. $ 165.6 Mn in the same year. The laboratories segment is anticipated to expand at a cumulative CAGR of 4.9% over the forecast period. Since there is an influx of funds for the research and development of innovative rapid testing kits, and the rising importance of smoking cessation around the world, laboratories are working round the clock for the same. Thus, they would be growing at a steady pace over the forecast period.
Competitive Landscape
The key players of this market are focusing on exhibiting and showcasing their product lines at various conventions and conferences to gain publicity for their products and thereby expand their businesses.
Nano-Ditech Corporation announced the successful representation of the company’s product lines in the Medlab 2017 held in Dubai from March 6th to 9th.
LifeSign LLC announced their participation in the 71st AACC Annual Scientific Meeting & Clinical Lab Expo in August 2019.
In November 2017, Ameritek USA successfully exhibited their upcoming product line in the Medica 2016 held in Germany.
Hangzhou Clongene Biotech Co., in August 2019 announced that they exhibited their new product lines in the 2019 AACC Annual Scientific Meeting & Clinical Lab Expo.
Continuous efforts taken by various governments to stop the growing burden of smoking tobacco and drug abuse, decreasing the popularity of smoking amongst pregnant women, growing interest in healthier lives will propel the demand for these screening devices in the upcoming years and present the manufacturers with many lucrative opportunities for growth and development.
Scope of the report
Attributes |
Details |
Forecast Period |
2022-2029 |
Historic Data available for |
2014-2021 |
Market Analysis |
USD Million for value |
Key Countries covered |
US, Canada, Germany, U.K., France, Italy, Spain, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, Turkey, South Africa. |
Key Segments covered |
Device Type, Sample Type, End-User & Region |
Key Companies Profiled |
|
Report Coverage |
Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
Customization and Pricing |
Available upon request |
Cotinine Screening Devices Market, By Category
Device Type:
- Cassettes
- Strips
- Reader
By Sample Type:
- Blood Sample
- Urine Sample
- Saliva Sample
By End-User:
- Hospitals
- Laboratories
- Clinics
- Workplace Screening Centers
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle-East & Africa
Frequently Asked Questions
Cotinine screening devices are used to detect the presence of nicotine in a person’s body, which depicts the use of tobacco in the recent past.
The global cotinine screening devices market was valued at U.S. $ 429.9 Mn in the year 2021 and is expected to expand at a CAGR of 4.7% over the forecast period (2022-2029)
The Key players of the Cotinine Screening Devices market are Abbott Laboratories, AlcoPro, Jant Pharmacal Corporation, Sinocare Inc., Mossman Associates, Nano-Ditech Corp, LifeSign LLC, ALFA Scientific, Ameritek USA., Hangzhou Clongene Biotech Co., and Germaine Laboratories, Inc.
Cassettes dominate the global cotinine screening devices market with a market share of more than 60% of the overall market in the year 2021.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Key Success Factors
4.1. Product Adoption / Usage Analysis
4.2. Pricing Analysis, by Region
5. Global Cotinine Screening Devices Market Demand (in Volume Units) Analysis 2014-2021 and Forecast, 2022-2029
5.1. Historical Market Volume (Units) Analysis, 2014-2021
5.2. Current and Future Market Volume (Units) Projections, 2022-2029
5.2.1. Y-o-Y Growth Trend Analysis
5.2.2. Absolute $ Opportunity Analysis
6. Global Cotinine Screening Devices Market - Pricing Analysis
6.1. Regional Pricing Analysis by Device Type
6.2. Pricing Break-up
6.2.1. Manufacture-level Pricing
6.2.2. Distributor-level Pricing
6.3. Global Average Pricing Analysis Benchmark
7. Global Cotinine Screening Devices Market Demand (in Value or Size in US$ Mn) Analysis 2014-2021 and Forecast, 2022-2029
7.1. Historical Market Value (US$ Mn) Analysis, 2014-2021
7.2. Current and Future Market Value (US$ Mn) and Projections, 2022-2029
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Market Background
8.1. Macro-Economic Factors
8.1.1. Global GDP Growth Outlook
8.1.2. Global Healthcare Outlook
8.1.3. Income Per Capita Outlook
8.1.4. Global Smoking Prevalence
8.1.5. Economic Impact of Smoking
8.2. Forecast Factors - Relevance & Impact
8.2.1. Number of Health & Life Insurance Purchases /p>
8.2.2. Awareness about Cotinine Testing
8.2.3. Availability of Cotinine Screening Devices
8.2.4. Cost of Cotinine Screening Devices
8.2.5. Adoption of Cotinine Screening Devices
8.3. Market Dynamics
8.3.1. Drivers
8.3.2. Restraints
8.3.3. Opportunity Analysis
9. Global Cotinine Screening Devices Market Analysis 2014-2021 and Forecast 2022-2029, by Device Type
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Device Types, 2014–2021
9.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Device Type, 2022-2029
9.3.1. Cassettes
9.3.2. Strips
9.3.3. Reader
9.4. Market Attractiveness Analysis By Device Type
10. Global Cotinine Screening Devices Market Analysis 2014-2021 and Forecast 2022-2029, by Sample Type
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By Sample Type, 2014–2021
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Sample Type, 2022-2029
10.3.1. Blood Sample
10.3.2. Urine Sample
10.3.3. Saliva Sample
10.4. Market Attractiveness Analysis By Device Type
11. Global Cotinine Screening Devices Market Analysis 2014-2021 and Forecast 2022-2029, by End Users
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis By End Users , 2014–2021
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End Users , 2022-2029
11.3.1. Hospitals
11.3.2. Laboratories
11.3.3. Clinics
11.3.4. Workplace Screening Centers
11.4. Market Attractiveness Analysis By End Users
12. Global Cotinine Screening Devices Market Analysis 2014-2021 and Forecast 2022-2029, by Region
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2014–2021
12.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Region, 2022-2029
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. East Asia
12.3.5. South Asia
12.3.6. Oceania
12.3.7. Middle East and Africa (MEA)
12.4. Market Attractiveness Analysis By Region
13. North America Cotinine Screening Devices Market Analysis 2014-2021 and Forecast 2022-2029
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Analysis and Volume (Units) By Market Taxonomy, 2014–2021
13.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022-2029
13.3.1. By Country
13.3.1.1. U.S.
13.3.1.2. Canada
13.3.2. By Device Type
13.3.3. By Sample Type
13.3.4. By End Users
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Device Type
13.4.3. By Sample Type
13.4.4. By End Users ;
13.5. Key Market Participants - Intensity Mapping
13.6. Drivers and Restraints - Impact Analysis
14. Latin America Cotinine Screening Devices Market Analysis 2014-2021 and Forecast 2022-2029
14.1. Introduction
14.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2014–2021
14.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022-2029
14.3.1. By Country
14.3.1.1. Brazil
14.3.1.2. Mexico
14.3.1.3. Rest of Latin America
14.3.2. By Device Type
14.3.3. By Sample Type
14.3.4. By End Users
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Device Type
14.4.3. By Sample Type
14.4.4. By End Users
14.5. Key Market Participants - Intensity Mapping
14.6. Drivers and Restraints - Impact Analysis
15. Europe Cotinine Screening Devices Market Analysis 2014-2021 and Forecast 2022-2029
15.1. Introduction
15.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2014–2021
15.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022-2029
15.3.1. By Country
15.3.1.1. Germany
15.3.1.2. Italy
15.3.1.3. France
15.3.1.4. U.K.
15.3.1.5. Spain
15.3.1.6. BENELUX
15.3.1.7. Russia
15.3.1.8. Rest of Europe
15.3.2. By Device Type
15.3.3. By Sample Type
15.3.4. By End Users
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Device Type
15.4.3. By Sample Type
15.4.4. By End Users
15.5. Key Market Participants - Intensity Mapping
15.6. Drivers and Restraints - Impact Analysis
16. South Asia Cotinine Screening Devices Market Analysis 2014-2021 and Forecast 2022-2029
16.1. Introduction
16.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2014–2021
16.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022-2029
16.3.1. By Country
16.3.1.1. India
16.3.1.2. Thailand
16.3.1.3. Indonesia
16.3.1.4. Malaysia
16.3.1.5. Rest of South Asia
16.3.2. By Device Type
16.3.3. By Sample Type
16.3.4. By End Users
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Device Type
16.4.3. By Sample Type
16.4.4. By End Users
16.5. Key Market Participants - Intensity Mapping
16.6. Drivers and Restraints - Impact Analysis
17. East Asia Cotinine Screening Devices Market Analysis 2014-2021 and Forecast 2022-2029
17.1. Introduction
17.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2014–2021
17.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022-2029
17.3.1. By Country
17.3.1.1. China
17.3.1.2. Japan
17.3.1.3. South Korea
17.3.2. By Device Type
17.3.3. By Sample Type
17.3.4. By End Users
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Device Type
17.4.3. By Sample Type
17.4.4. By End Users
17.5. Key Market Participants - Intensity Mapping
17.6. Drivers and Restraints - Impact Analysis
18. Oceania Cotinine Screening Devices Market Analysis 2014-2021 and Forecast 2022-2029
18.1. Introduction
18.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2014–2021
18.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022-2029
18.3.1. By Country
18.3.1.1. Australia
18.3.1.2. New Zealand
18.3.2. By Device Type
18.3.3. By Sample Type
18.3.4. By End Users
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Device Type
18.4.3. By Sample Type
18.4.4. By End Users
18.5. Key Market Participants - Intensity Mapping
18.6. Drivers and Restraints - Impact Analysis
19. Middle East and Africa Cotinine Screening Devices Market Analysis 2014-2021 and Forecast 2022-2029
19.1. Introduction
19.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market Taxonomy, 2014–2021
19.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2022-2029
19.3.1. By Country
19.3.1.1. GCC Countries
19.3.1.2. Turkey
19.3.1.3. Northern Africa
19.3.1.4. South Africa
19.3.1.5. Rest of Middle East and Africa
19.3.2. By Device Type
19.3.3. By Sample Type
19.3.4. By End Users
19.4. Market Attractiveness Analysis
19.4.1. By Country
19.4.2. By Device Type
19.4.3. By Sample Type
19.4.4. By End Users
19.5. Key Market Participants - Intensity Mapping
19.6. Drivers and Restraints - Impact Analysis
20. Emerging Countries Cotinine Screening Devices Market Analysis 2014-2021 and Forecast 2022-2029
20.1. Introduction
20.1.1. Market Value Proportion Analysis, By Key Countries
20.1.2. Global vs. Country Growth Comparison
20.2. China Cotinine Screening Devices Market Analysis
20.2.1. Introduction
20.2.2. PEST Analysis
20.2.3. Market Value Proportion Analysis by Market taxonomy
20.2.4. Market Value (US$ Mn) and Volume (Units)Analysis and Forecast by Market Taxonomy
20.2.4.1. By Device Type
20.2.4.2. By Sample Type
20.2.4.3. By End-User
20.2.5. China Cotinine Screening Devices Competitive Landscape
20.3. India Cotinine Screening Devices Market Analysis
20.3.1. Introduction
20.3.2. PEST Analysis
20.3.3. Market Value Proportion Analysis by Market taxonomy
20.3.4. Market Value (US$ Mn) and Volume (Units)Analysis and Forecast by Market Taxonomy
20.3.4.1. By Device Type
20.3.4.2. By Sample Type
20.3.4.3. By End-User
20.3.5. India Cotinine Screening Devices Competitive Landscape
20.4. Brazil Cotinine Screening Devices Market Analysis
20.4.1. Introduction
20.4.2. PEST Analysis
20.4.3. Market Value Proportion Analysis by Market taxonomy
20.4.4. Market Value (US$ Mn) and Volume (Units)Analysis and Forecast by Market Taxonomy
20.4.4.1. By Device Type
20.4.4.2. By Sample Type
20.4.4.3. By End-User
20.4.5. Brazil Cotinine Screening Devices Competitive Landscape
21. Market Structure Analysis
21.1. Market Analysis by Tier of Companies
21.2. Market Share Analysis of Top Players
21.3. Market Presence Analysis
21.3.1. By Regional footprint of Players
21.3.2. Product foot print by Players
21.3.3. Channel Foot Print by Players
22. Competition Analysis
22.1. Competition Dashboard
22.2. Competition Benchmarking
22.3. Competition Deep Dive
22.3.1. Abbott
22.3.1.1. Overview
22.3.1.2. Product Portfolio
22.3.1.3. Profitability by Market Segments (Product/Channel/Region)
22.3.1.4. Sales Footprint
22.3.1.5. Strategy Overview
22.3.1.5.1. Marketing Strategy
22.3.1.5.2. Product Strategy
22.3.1.5.3. Channel Strategy
22.3.2. AlcoPro
22.3.2.1. Overview
22.3.2.2. Product Portfolio
22.3.2.3. Profitability by Market Segments (Product/Channel/Region)
22.3.2.4. Sales Footprint
22.3.2.5. Strategy Overview
22.3.2.5.1. Marketing Strategy
22.3.2.5.2. Product Strategy
22.3.2.5.3. Channel Strategy
22.3.3. Jant Pharmacal Corporation
22.3.3.1. Overview
22.3.3.2. Product Portfolio
22.3.3.3. Profitability by Market Segments (Product/Channel/Region)
22.3.3.4. Sales Footprint
22.3.3.5. Strategy Overview
22.3.3.5.1. Marketing Strategy
22.3.3.5.2. Product Strategy
22.3.3.5.3. Channel Strategy
22.3.4. Sinocare Inc.
22.3.4.1. Overview
22.3.4.2. Product Portfolio
22.3.4.3. Profitability by Market Segments (Product/Channel/Region)
22.3.4.4. Sales Footprint
22.3.4.5. Strategy Overview
22.3.4.5.1. Marketing Strategy
22.3.4.5.2. Product Strategy
22.3.4.5.3. Channel Strategy
22.3.5. Mossman Associates
22.3.5.1. Overview
22.3.5.2. Product Portfolio
22.3.5.3. Profitability by Market Segments (Product/Channel/Region)
22.3.5.4. Sales Footprint
22.3.5.5. Strategy Overview
22.3.5.5.1. Marketing Strategy
22.3.5.5.2. Product Strategy
22.3.5.5.3. Channel Strategy
22.3.6. Nano-Ditech Corp
22.3.6.1. Overview
22.3.6.2. Product Portfolio
22.3.6.3. Profitability by Market Segments (Product/Channel/Region)
22.3.6.4. Sales Footprint
22.3.6.5. Strategy Overview
22.3.6.5.1. Marketing Strategy
22.3.6.5.2. Product Strategy
22.3.6.5.3. Channel Strategy
22.3.7. LifeSign LLC
22.3.7.1. Overview
22.3.7.2. Product Portfolio
22.3.7.3. Profitability by Market Segments (Product/Channel/Region)
22.3.7.4. Sales Footprint
22.3.7.5. Strategy Overview
22.3.7.5.1. Marketing Strategy
22.3.7.5.2. Product Strategy
22.3.7.5.3. Channel Strategy
22.3.8. ALFA Scientific
22.3.8.1. Overview
22.3.8.2. Product Portfolio
22.3.8.3. Profitability by Market Segments (Product/Channel/Region)
22.3.8.4. Sales Footprint
22.3.8.5. Strategy Overview
22.3.8.5.1. Marketing Strategy
22.3.8.5.2. Product Strategy
22.3.8.5.3. Channel Strategy
22.3.9. Ameritek USA.
22.3.9.1. Overview
22.3.9.2. Product Portfolio
22.3.9.3. Profitability by Market Segments (Product/Channel/Region)
22.3.9.4. Sales Footprint
22.3.9.5. Strategy Overview
22.3.9.5.1. Marketing Strategy
22.3.9.5.2. Product Strategy
22.3.9.5.3. Channel Strategy
22.3.10. Hangzhou Clongene Biotech Co.
22.3.10.1. Overview
22.3.10.2. Product Portfolio
22.3.10.3. Profitability by Market Segments (Product/Channel/Region)
22.3.10.4. Sales Footprint
22.3.10.5. Strategy Overview
22.3.10.5.1. Marketing Strategy
22.3.10.5.2. Product Strategy
22.3.10.5.3. Channel Strategy
22.3.11. Germaine Laboratories, Inc.
22.3.11.1. Overview
22.3.11.2. Product Portfolio
22.3.11.3. Profitability by Market Segments (Product/Channel/Region)
22.3.11.4. Sales Footprint
22.3.11.5. Strategy Overview
22.3.11.5.1. Marketing Strategy
22.3.11.5.2. Product Strategy
22.3.11.5.3. Channel Strategy
23. Assumptions and Acronyms Used
24. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 01: Expenditure on Health, (% of GDP), by Country, 2016 - 2021
Table 02: Expenditure on Health, (% of GDP), by Country, 2016 - 2021
Table 03: Global Cotinine Screening Devices Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Device Type
Table 04: Global Cotinine Screening Devices Market Size Test Volume (Mn Units) Analysis 2014-2021 and Forecast 2022-2029, By Device Type
Table 05: Global Cotinine Screening Devices Market Size Device Volume (Mn Units) Analysis 2014-2021 and Forecast 2022-2029
Table 06: Global Cotinine Screening Devices Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Sample Type
Table 07: Global Cotinine Screening Devices Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User
Table 08: Global Cotinine Screening Devices Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Region
Table 09: North America Cotinine Screening Devices Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country
Table 10: North America Cotinine Screening Devices Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Device Type
Table 11: North America Cotinine Screening Devices Market Size Test Volume (Mn Units) Analysis 2014-2021 and Forecast 2022-2029, By Device Type
Table 12: North America Cotinine Screening Devices Market Size Device Volume (Mn Units) Analysis 2014-2021 and Forecast 2022-2029
Table 13: North America Cotinine Screening Devices Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Sample Type
Table 14: North America Cotinine Screening Devices Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User
Table 15: Latin America Cotinine Screening Devices Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country
Table 16: Latin America Cotinine Screening Devices Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Device Type
Table 17: Latin America Cotinine Screening Devices Market Size Test Volume (Mn Units) Analysis 2014-2021 and Forecast 2022-2029, By Device Type
Table 18: Latin America Cotinine Screening Devices Market Size Device Volume (Mn Units) Analysis 2014-2021 and Forecast 2022-2029
Table 19: Latin America Cotinine Screening Devices Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Sample Type
Table 20: Latin America Cotinine Screening Devices Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User
Table 21: Europe Cotinine Screening Devices Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country
Table 22: Europe Cotinine Screening Devices Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Device Type
Table 23: Europe Cotinine Screening Devices Market Size Test Volume (Mn Units) Analysis 2014-2021 and Forecast 2022-2029, By Device Type
Table 24: Europe Cotinine Screening Devices Market Size Device Volume (Mn Units) Analysis 2014-2021 and Forecast 2022-2029
Table 25: Europe Cotinine Screening Devices Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Sample Type
Table 26: Europe Cotinine Screening Devices Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User
Table 27: South Asia Cotinine Screening Devices Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country
Table 28: South Asia Cotinine Screening Devices Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Device Type
Table 29: South Asia Cotinine Screening Devices Market Size Test Volume (Mn Units) Analysis 2014-2021 and Forecast 2022-2029, By Device Type
Table 30: South Asia Cotinine Screening Devices Market Size Device Volume (Mn Units) Analysis 2014-2021 and Forecast 2022-2029
Table 31: South Asia Cotinine Screening Devices Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Sample Type
Table 32: South Asia Cotinine Screening Devices Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User
Table 33: East Asia Cotinine Screening Devices Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country
Table 34: East Asia Cotinine Screening Devices Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Device Type
Table 35: East Asia Cotinine Screening Devices Market Size Test Volume (Mn Units) Analysis 2014-2021 and Forecast 2022-2029, By Device Type
Table 36: East Asia Cotinine Screening Devices Market Size Device Volume (Mn Units) Analysis 2014-2021 and Forecast 2022-2029
Table 37: East Asia Cotinine Screening Devices Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Sample Type
Table 38: East Asia Cotinine Screening Devices Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User
Table 39: Oceania Cotinine Screening Devices Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country
Table 40: Oceania Cotinine Screening Devices Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Device Type
Table 41: Oceania Cotinine Screening Devices Market Size Test Volume (Mn Units) Analysis 2014-2021 and Forecast 2022-2029, By Device Type
Table 42: Oceania Cotinine Screening Devices Market Size Device Volume (Mn Units) Analysis 2014-2021 and Forecast 2022-2029
Table 43: Oceania Cotinine Screening Devices Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Sample Type
Table 44: Oceania Cotinine Screening Devices Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User
Table 45: MEA Cotinine Screening Devices Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Country
Table 46: MEA Cotinine Screening Devices Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Device Type
Table 47: MEA Cotinine Screening Devices Market Size Test Volume (Mn Units) Analysis 2014-2021 and Forecast 2022-2029, By Device Type
Table 48: MEA Cotinine Screening Devices Market Size Device Volume (Mn Units) Analysis 2014-2021 and Forecast 2022-2029
Table 49: MEA Cotinine Screening Devices Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Sample Type
Table 50: MEA Cotinine Screening Devices Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User
Table 51: China Cotinine Screening Devices Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Device Type
Table 52: China Cotinine Screening Devices Market Size Test Volume (Mn Units) Analysis 2014-2021 and Forecast 2022-2029, By Device Type
Table 53: China Cotinine Screening Devices Market Size Device Volume (Mn Units) Analysis 2014-2021 and Forecast 2022-2029
Table 54: China Cotinine Screening Devices Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Sample Type
Table 55: China Cotinine Screening Devices Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User
Table 56: India Cotinine Screening Devices Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Device Type
Table 57: India Cotinine Screening Devices Market Size Test Volume (Mn Units) Analysis 2014-2021 and Forecast 2022-2029, By Device Type
Table 58: India Cotinine Screening Devices Market Size Device Volume (Mn Units) Analysis 2014-2021 and Forecast 2022-2029
Table 59: India Cotinine Screening Devices Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Sample Type
Table 60: India Cotinine Screening Devices Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End User
Table 61: Brazil Cotinine Screening Devices Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Device Type
Table 62: Brazil Cotinine Screening Devices Market Size Test Volume (Mn Units) Analysis 2014-2021 and Forecast 2022-2029, By Device Type
Table 63: Brazil Cotinine Screening Devices Market Size Device Volume (Mn Units) Analysis 2014-2021 and Forecast 2022-2029
Table 64: Brazil Cotinine Screening Devices Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Sample Type
Table 65: Brazil Cotinine Screening Devices Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By End Use
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 01: Global Cotinine Screening Devices Market Share, By Device Type (2021)
Figure 02: Global Cotinine Screening Devices Market Share, Sample Type (2021)
Figure 03: Global Cotinine Screening Devices Market Share, By End User (2021)
Figure 04: Global Cotinine Screening Devices Market Share, By Region (2021)
Figure 05: Global Cotinine Screening Devices Historical Market Size and Y-o-Y, 2014-2021
Figure 06: Global Cotinine Screening Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2029
Figure 07: Global Cotinine Screening Devices Market Absolute $ Opportunity, 2014–2029
Figure 08: Global Cotinine Screening Devices Market Analysis by Device Type –2022 & 2029
Figure 09: Global Cotinine Screening Devices Market Y-o-Y Growth Projections by Device Type, 2022–2029
Figure 10: Global Cotinine Screening Devices Market Attractiveness Analysis, By Device Type
Figure 11: Global Cotinine Screening Devices Market Analysis by Sample Type –2022 & 2029
Figure 12: Global Cotinine Screening Devices Market Y-o-Y Growth Projections by Sample Type, 2022–2029
Figure 13: Global Cotinine Screening Devices Market Attractiveness Analysis, By Sample Type
Figure 14: Global Cotinine Screening Devices Market Analysis by End User –2022 & 2029
Figure 15: Global Cotinine Screening Devices Market Y-o-Y Growth Projections by End User, 2022–2029
Figure 16: Global Cotinine Screening Devices Market Attractiveness Analysis, By End User
Figure 17: Global Cotinine Screening Devices Market Analysis by Region –2022 & 2029
Figure 18: Global Cotinine Screening Devices Market Y-o-Y Growth Projections by Region, 2022–2029
Figure 19: Global Cotinine Screening Devices Market Size (US$ Mn) Analysis 2014-2021 and Forecast 2022-2029, By Region
Figure 20: North America Cotinine Screening Devices Market Size (US$ Mn) Analysis, 2014–2021
Figure 21: North America Cotinine Screening Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2029
Figure 22: North America Cotinine Screening Devices Market Analysis by Country –2022 & 2029
Figure 23: North America Cotinine Screening Devices Market Y-o-Y Growth Projections by Country, 2022–2029
Figure 24: North America Cotinine Screening Devices Market Attractiveness Analysis by Country, 2022–2029
Figure 25: North America Cotinine Screening Devices Market Analysis by Device Type–2022 & 2029
Figure 26: North America Cotinine Screening Devices Market Y-o-Y Growth Projections by Device Type, 2022–2029
Figure 27: North America Cotinine Screening Devices Market Attractiveness Analysis by Device Type, 2022–2029
Figure 28: North America Cotinine Screening Devices Market Analysis by Sample Type – 2022 & 2029
Figure 29: North America Cotinine Screening Devices Market Y-o-Y Growth Projections by Sample Type, 2022–2029
Figure 30: North America Cotinine Screening Devices Market Attractiveness Analysis by Sample Type, 2022–2029
Figure 31: North America Cotinine Screening Devices Market Analysis by End User – 2022 & 2029
Figure 32: North America Cotinine Screening Devices Market Y-o-Y Growth Projections by End User, 2022–2029
Figure 33: North America Cotinine Screening Devices Market Attractiveness Analysis by End User, 2022–2029
Figure 34: Latin America Cotinine Screening Devices Market Size (US$ Mn) Analysis, 2014–2021
Figure 35: Latin America Cotinine Screening Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2029
Figure 36: Latin America Cotinine Screening Devices Market Analysis by Country –2022 & 2029
Figure 37: Latin America Cotinine Screening Devices Market Y-o-Y Growth Projections by Country, 2022–2029
Figure 38: Latin America Cotinine Screening Devices Market Attractiveness Analysis by Country, 2022–2029
Figure 39: Latin America Cotinine Screening Devices Market Analysis by Device Type–2022 & 2029
Figure 40: Latin America Cotinine Screening Devices Market Y-o-Y Growth Projections by Device Type, 2022–2029
Figure 41: Latin America Cotinine Screening Devices Market Attractiveness Analysis by Device Type, 2022–2029
Figure 42: Latin America Cotinine Screening Devices Market Analysis by Sample Type – 2022 & 2029
Figure 43: Latin America Cotinine Screening Devices Market Y-o-Y Growth Projections by Sample Type, 2022–2029
Figure 44: Latin America Cotinine Screening Devices Market Attractiveness Analysis by Sample Type, 2022–2029
Figure 45: Latin America Cotinine Screening Devices Market Analysis by End User – 2022 & 2029
Figure 46: Latin America Cotinine Screening Devices Market Y-o-Y Growth Projections by End User, 2022–2029
Figure 47: Latin America Cotinine Screening Devices Market Attractiveness Analysis by End User, 2022–2029
Figure 48: Europe Cotinine Screening Devices Market Size (US$ Mn) Analysis, 2014–2021
Figure 49: Europe Cotinine Screening Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2029
Figure 50: Europe Cotinine Screening Devices Market Analysis by Country –2022 & 2029
Figure 51: Europe Cotinine Screening Devices Market Y-o-Y Growth Projections by Country, 2022–2029
Figure 52: Europe Cotinine Screening Devices Market Attractiveness Analysis by Country, 2022–2029
Figure 53: Europe Cotinine Screening Devices Market Analysis by Device Type–2022 & 2029
Figure 54: Europe Cotinine Screening Devices Market Y-o-Y Growth Projections by Device Type, 2022–2029
Figure 55: Europe Cotinine Screening Devices Market Attractiveness Analysis by Device Type, 2022–2029
Figure 56: Europe Cotinine Screening Devices Market Analysis by Sample Type – 2022 & 2029
Figure 57: Europe Cotinine Screening Devices Market Y-o-Y Growth Projections by Sample Type, 2022–2029
Figure 58: Europe Cotinine Screening Devices Market Attractiveness Analysis by Sample Type, 2022–2029
Figure 59: Europe Cotinine Screening Devices Market Analysis by End User – 2022 & 2029
Figure 60: Europe Cotinine Screening Devices Market Y-o-Y Growth Projections by End User, 2022–2029
Figure 61: Europe Cotinine Screening Devices Market Attractiveness Analysis by End User, 2022–2029
Figure 62: South Asia Cotinine Screening Devices Market Size (US$ Mn) Analysis, 2014–2021
Figure 63: South Asia Cotinine Screening Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2029
Figure 64: South Asia Cotinine Screening Devices Market Analysis by Country –2022 & 2029
Figure 65: South Asia Cotinine Screening Devices Market Y-o-Y Growth Projections by Country, 2022–2029
Figure 66: South Asia Cotinine Screening Devices Market Attractiveness Analysis by Country, 2022–2029
Figure 67: South Asia Cotinine Screening Devices Market Analysis by Device Type–2022 & 2029
Figure 68: South Asia Cotinine Screening Devices Market Y-o-Y Growth Projections by Device Type, 2022–2029
Figure 69: South Asia Cotinine Screening Devices Market Attractiveness Analysis by Device Type, 2022–2029
Figure 70: South Asia Cotinine Screening Devices Market Analysis by Sample Type – 2022 & 2029
Figure 71: South Asia Cotinine Screening Devices Market Y-o-Y Growth Projections by Sample Type, 2022–2029
Figure 72: South Asia Cotinine Screening Devices Market Attractiveness Analysis by Sample Type, 2022–2029
Figure 73: South Asia Cotinine Screening Devices Market Analysis by End User – 2022 & 2029
Figure 74: South Asia Cotinine Screening Devices Market Y-o-Y Growth Projections by End User, 2022–2029
Figure 75: South Asia Cotinine Screening Devices Market Attractiveness Analysis by End User, 2022–2029
Figure 76: East Asia Cotinine Screening Devices Market Size (US$ Mn) Analysis, 2014–2021
Figure 77: East Asia Cotinine Screening Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2029
Figure 78: East Asia Cotinine Screening Devices Market Analysis by Country –2022 & 2029
Figure 79: East Asia Cotinine Screening Devices Market Y-o-Y Growth Projections by Country, 2022–2029
Figure 80: East Asia Cotinine Screening Devices Market Attractiveness Analysis by Country, 2022–2029
Figure 81: East Asia Cotinine Screening Devices Market Analysis by Device Type–2022 & 2029
Figure 82: East Asia Cotinine Screening Devices Market Y-o-Y Growth Projections by Device Type, 2022–2029
Figure 83: East Asia Cotinine Screening Devices Market Attractiveness Analysis by Device Type, 2022–2029
Figure 84: East Asia Cotinine Screening Devices Market Analysis by Sample Type – 2022 & 2029
Figure 85: East Asia Cotinine Screening Devices Market Y-o-Y Growth Projections by Sample Type, 2022–2029
Figure 86: East Asia Cotinine Screening Devices Market Attractiveness Analysis by Sample Type, 2022–2029
Figure 87: East Asia Cotinine Screening Devices Market Analysis by End User – 2022 & 2029
Figure 88: East Asia Cotinine Screening Devices Market Y-o-Y Growth Projections by End User, 2022–2029
Figure 89: East Asia Cotinine Screening Devices Market Attractiveness Analysis by End User, 2022–2029
Figure 90: Oceania Cotinine Screening Devices Market Size (US$ Mn) Analysis, 2014–2021
Figure 91: Oceania Cotinine Screening Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2029
Figure 92: Oceania Cotinine Screening Devices Market Analysis by Country –2022 & 2029
Figure 93: Oceania Cotinine Screening Devices Market Y-o-Y Growth Projections by Country, 2022–2029
Figure 94: Oceania Cotinine Screening Devices Market Attractiveness Analysis by Country, 2022–2029
Figure 95: Oceania Cotinine Screening Devices Market Analysis by Device Type–2022 & 2029
Figure 96: Oceania Cotinine Screening Devices Market Y-o-Y Growth Projections by Device Type, 2022–2029
Figure 97: Oceania Cotinine Screening Devices Market Attractiveness Analysis by Device Type, 2022–2029
Figure 98: Oceania Cotinine Screening Devices Market Analysis by Sample Type – 2022 & 2029
Figure 99: Oceania Cotinine Screening Devices Market Y-o-Y Growth Projections by Sample Type, 2022–2029
Figure 100: Oceania Cotinine Screening Devices Market Attractiveness Analysis by Sample Type, 2022–2029
Figure 101: Oceania Cotinine Screening Devices Market Analysis by End User – 2022 & 2029
Figure 102: Oceania Cotinine Screening Devices Market Y-o-Y Growth Projections by End User, 2022–2029
Figure 103: Oceania Cotinine Screening Devices Market Attractiveness Analysis by End User, 2022–2029
Figure 104: MEA Cotinine Screening Devices Market Size (US$ Mn) Analysis, 2014–2021
Figure 105: MEA Cotinine Screening Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2029
Figure 106: MEA Cotinine Screening Devices Market Analysis by Country –2022 & 2029
Figure 107: MEA Cotinine Screening Devices Market Y-o-Y Growth Projections by Country, 2022–2029
Figure 108: MEA Cotinine Screening Devices Market Attractiveness Analysis by Country, 2022–2029
Figure 109: MEA Cotinine Screening Devices Market Analysis by Device Type–2022 & 2029
Figure 110: MEA Cotinine Screening Devices Market Y-o-Y Growth Projections by Device Type, 2022–2029
Figure 111: MEA Cotinine Screening Devices Market Attractiveness Analysis by Device Type, 2022–2029
Figure 112: MEA Cotinine Screening Devices Market Analysis by Sample Type – 2022 & 2029
Figure 113: MEA Cotinine Screening Devices Market Y-o-Y Growth Projections by Sample Type, 2022–2029
Figure 114: MEA Cotinine Screening Devices Market Attractiveness Analysis by Sample Type, 2022–2029
Figure 115: MEA Cotinine Screening Devices Market Analysis by End User – 2022 & 2029
Figure 116: MEA Cotinine Screening Devices Market Y-o-Y Growth Projections by End User, 2022–2029
Figure 117: MEA Cotinine Screening Devices Market Attractiveness Analysis by End User, 2022–2029
Figure 118: China Cotinine Screening Devices Market Size (US$ Mn) Analysis, 2014–2021
Figure 119: China Cotinine Screening Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2029
Figure 120: China Cotinine Screening Devices Market Size (US$ Mn) Analysis, 2014–2021
Figure 121: China Cotinine Screening Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2029
Figure 122: China Cotinine Screening Devices Market Analysis by Device Type–2022 & 2029
Figure 123: China Cotinine Screening Devices Market Y-o-Y Growth Projections by Device Type, 2022–2029
Figure 124: China Cotinine Screening Devices Market Attractiveness Analysis by Device Type, 2022–2029
Figure 125: China Cotinine Screening Devices Market Analysis by Sample Type – 2022 & 2029
Figure 126: China Cotinine Screening Devices Market Y-o-Y Growth Projections by Sample Type, 2022–2029
Figure 127: China Cotinine Screening Devices Market Attractiveness Analysis by Sample Type, 2022–2029
Figure 128: China Cotinine Screening Devices Market Analysis by End User – 2022 & 2029
Figure 129: China Cotinine Screening Devices Market Y-o-Y Growth Projections by End User, 2022–2029
Figure 130: China Cotinine Screening Devices Market Attractiveness Analysis by End User, 2022–2029
Figure 131: India Cotinine Screening Devices Market Size (US$ Mn) Analysis, 2014–2021
Figure 132: India Cotinine Screening Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2029
Figure 133: India Cotinine Screening Devices Market Analysis by Device Type–2022 & 2029
Figure 134: India Cotinine Screening Devices Market Y-o-Y Growth Projections by Device Type, 2022–2029
Figure 135: India Cotinine Screening Devices Market Attractiveness Analysis by Device Type, 2022–2029
Figure 136: India Cotinine Screening Devices Market Analysis by Sample Type – 2022 & 2029
Figure 137: India Cotinine Screening Devices Market Y-o-Y Growth Projections by Sample Type, 2022–2029
Figure 138: India Cotinine Screening Devices Market Attractiveness Analysis by Sample Type, 2022–2029
Figure 139: India Cotinine Screening Devices Market Analysis by End User – 2022 & 2029
Figure 140: India Cotinine Screening Devices Market Y-o-Y Growth Projections by End User, 2022–2029
Figure 141: India Cotinine Screening Devices Market Attractiveness Analysis by End User, 2022–2029
Figure 142: Brazil Cotinine Screening Devices Market Size (US$ Mn) Analysis, 2014–2021
Figure 143: Brazil Cotinine Screening Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2029
Figure 144: Brazil Cotinine Screening Devices Market Analysis by Device Type–2022 & 2029
Figure 145: Brazil Cotinine Screening Devices Market Y-o-Y Growth Projections by Device Type, 2022–2029
Figure 146: Brazil Cotinine Screening Devices Market Attractiveness Analysis by Device Type, 2022–2029
Figure 147: Brazil Cotinine Screening Devices Market Analysis by Sample Type – 2022 & 2029
Figure 148: Brazil Cotinine Screening Devices Market Y-o-Y Growth Projections by Sample Type, 2022–2029
Figure 149: Brazil Cotinine Screening Devices Market Attractiveness Analysis by Sample Type, 2022–2029
Figure 150: Brazil Cotinine Screening Devices Market Analysis by End User – 2022 & 2029
Figure 151: Brazil Cotinine Screening Devices Market Y-o-Y Growth Projections by End User, 2022–2029
Figure 152: Brazil Cotinine Screening Devices Market Attractiveness Analysis by End User, 2022–202
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports